2018 Year in Review

FDNA’s Face2Gene technology is now being used by more than 70% of clinical geneticists at over 2,000 institutions in 130 countries.
It was an exciting 2018 for FDNA, as we continued on our path to bring AI-based phenotyping technologies to clinicians, researchers, and labs globally. Take a look below for a recap of what the FDNA team was up to in 2018.

Events & Presentations

Watch All Webinars & Presentations>> | Read More on FDNA Insights>>

In The News

DeepGestalt In The News
See All of FDNA In The News>>

Publications

See All Publications>>

Announcements

  • FDNA Publishes Study in Nature Medicine Defining New Artificial Intelligence Standard in Healthcare Read More>>
  • FDNA Announces 100,000 Patients’ Lives Impacted Through Face2Gene Read More>>
  • FDNA Expands Leadership Team Read More>>
  • Send the phenotype to the lab with Face2Gene CLINIC Learn How>>
See All Announcements>>

Related articles